C4 Therapeutics Inc (NASDAQ:CCCC) traded at $1.40 at close of the session on Monday, April 21 and made an upward move of 12.00% on its previous day’s price. Looking at the stock we see that its previous close was $1.25 and the beta (5Y monthly)
C4 Therapeutics Inc (NASDAQ:CCCC) price on Thursday, April 10, fall -6.92% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.21. A look at the stock’s price movement, the close in the last trading session was $1.30, moving
C4 Therapeutics Inc (NASDAQ:CCCC) price closed lower on Friday, April 04, and dropping -4.73% below its previous close. A look at the daily price movement shows that the last close reads $1.38, with intraday deals fluctuated between $1.27 and $1.365. The company’s 5Y monthly beta
C4 Therapeutics Inc (NASDAQ:CCCC) shares, rose in value on Friday, March 28, with the stock price down by -4.89% to the previous day’s close as strong demand from buyers drove the stock to $1.75. Actively observing the price movement in the last trading, the stock
The trading price of C4 Therapeutics Inc (NASDAQ:CCCC) closed lower on Friday, March 21, and closing at $2.12, -3.20% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $2.08 and $2.185. In examining the
C4 Therapeutics Inc (NASDAQ:CCCC) shares, rose in value, with the stock price up by 2.10% to the previous day’s close as strong demand from buyers drove the stock to $2.43. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
